BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38506084)

  • 1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
    Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
    J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
    Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
    J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
    Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
    Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
    Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
    Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin32 activates necroptosis through Src-mediated inhibition of caspase 8 in hepatocellular carcinoma.
    Xiang YK; Peng FH; Guo YQ; Ge H; Cai SY; Fan LX; Peng YX; Wen H; Wang Q; Tao L
    Cancer Sci; 2021 Sep; 112(9):3507-3519. PubMed ID: 34050696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Qiu DZ; Zhang ZJ; Wu WZ; Yang YK
    BMC Complement Altern Med; 2013 Jul; 13():185. PubMed ID: 23870199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.
    Yeh CB; Hsieh MJ; Hsieh YH; Chien MH; Chiou HL; Yang SF
    PLoS One; 2012; 7(2):e31055. PubMed ID: 22363545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
    Chen Y; Lin C; Liu Y; Jiang Y
    Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.
    Zhang Y; Wang S; Liu Z; Yang L; Liu J; Xiu M
    J Cell Mol Med; 2019 Jul; 23(7):4523-4533. PubMed ID: 31044528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating CXCR4/Wnt/β-Catenin Axis.
    Song X; Ding F; Luo W; Tao J; Yang K; Li Q; Zhang Z
    Acta Biochim Pol; 2023 Feb; 70(1):117-122. PubMed ID: 36735564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
    Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
    Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ Coactivator-1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ-Dependent WNT/β-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis.
    Zuo Q; He J; Zhang S; Wang H; Jin G; Jin H; Cheng Z; Tao X; Yu C; Li B; Yang C; Wang S; Lv Y; Zhao F; Yao M; Cong W; Wang C; Qin W
    Hepatology; 2021 Feb; 73(2):644-660. PubMed ID: 32298475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
    Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma.
    Xu L; Wang P; Feng X; Tang J; Li L; Zheng X; Zhang J; Hu Y; Lan T; Yuan K; Zhang Y; Ren S; Hao X; Zhang M; Xu M
    Clin Sci (Lond); 2019 Oct; 133(20):2085-2105. PubMed ID: 31654063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells.
    Jiang HL; Yu H; Ma X; Xu D; Lin GF; Ma DY; Jin JZ
    Tumour Biol; 2014 Jul; 35(7):6955-60. PubMed ID: 24740565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of XRCC5 is associated with metastasis through Wnt signaling pathway and predicts poor prognosis in patients with hepatocellular carcinoma.
    Liu ZH; Wang N; Wang FQ; Dong Q; Ding J
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7835-7847. PubMed ID: 31599408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.